As shown in Fig. 7A-D, SC79 (a specific AKT activator) invalidated the inhibitory effects of HECW2 knockdown on the proliferation, migration, and chemoresistance of CRC cells. This evidence concerns the gene AKT1 and colorectal carcinoma.